Funding for this research was provided by:
Innovative Research Groups of National Natural Science Foundation of China (81721091)
Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019-I2M-5-030/2019RU019)
National S&T Major Project of China (2018ZX10301201-008, 2017ZX100203205)
Zhejiang Provincial Public Welfare Technology Research Program (LGF18C100001)
Zhejiang International Science and Technology Cooperation Project (2016C04003)
National Key Research and Development Program of China (2018YFC2000501)
Received: 18 February 2020
Accepted: 30 October 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: The research was performed in accordance with the principles of the Declaration of Helsinki. The study was approved by the Ethical Review Committee of First Affiliated Hospital, School of Medicine, Zhejiang University (2014-334). Written informed consents, which included “Informed consent form and information collection,” “Informed consent form for scientific research,” and “Operation informed consent” have been signed by all participants.
: Not applicable.
: The authors declare that they have no competing interests.